VA
Valneva SE
VALN · NASDAQ
$6.56 +0.15% (+$0.01)
1M -2.81%
Market Cap 541.7M €
P/E Ratio -
Div. Yield -
ROE 152.63%
Piotroski F-Score Weak
1/9Valuation
32 /100
Expensive P/S 3.77x
P/B 6.68x
P/E N/A
Growth
0 /100
Declining Rev. growth 21.52%
Book val. growth 21.54%
EPS growth N/A
Profitability
4 /100
Weak Gross margin 16.35%
FCF margin 59.70%
Net margin 110.21%
Quality
5 /100
Poor ROIC 37.97%
Asset turnover 0.37x
ROE 152.63%
Debt
23 /100
High Debt/Equity 2.59x
Int. coverage -2.83x
Current ratio 2.16x
Stability
16 /100
Unstable Beta 1.35x
Profitable years 0
Rev. volatility 37.20%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na VALN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Thomas Lingelbach
Employees
674
Headquarters
Saint-Herblain
Nadcházející události
19 LIS
Earnings
Upcoming earnings report